Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle

Foodborne Pathog Dis. 2009 Sep;6(7):871-7. doi: 10.1089/fpd.2009.0290.

Abstract

Objective: To quantify the efficacy of a siderophore receptor and porin (SRP) proteins-based vaccine on the burden of Escherichia coli O157:H7 in feedlot cattle.

Methods: Two research trials were conducted in field conditions. In each trial, cattle (n = 1252 in trial #1; n = 1284 in trial #2) were systematically divided into 20 pens and were administered either the E. coli O157 SRP vaccine or a placebo (trial #1: days 0 and 21; trial #2: days 0, 21, and 42). Rectal fecal samples were collected on day 0, and pen floor samples were collected on days 21, 35, 70, and 85 for trial #1 and on days 42 and 98 for trial #2. On day 85 of trial #1, rectoanal mucosal swab samples and hide swab samples were collected. Cattle were weighed on days 0, 21, and 85 (trial #1) or 1 week before harvest (trial #2).

Results: In trial #1, prevalence of E. coli in the feces was lower in vaccinates compared to control animals (p = 0.04). On day 85, the likelihood of an animal being positive at any site was less among vaccinates than controls (p = 0.02). In trail #2, vaccination with SRP was associated with reduced shedding by 85.2% on day 98 (p < 0.01) but not on days 0 or 42. Vaccination with SRP was associated with a 98.2% reduction in concentration of E. coli O157 in fecal samples (2.54 vs. 0.80 log MPN/g of feces; p < 0.01). Cattle performance was not affected by SRP administration.

Conclusions: The E. coli O157:H7 SRP-based vaccine might serve as a preharvest intervention to reduce the burden of E. coli O157:H7 on cattle presented for harvest.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Animal Husbandry / methods
  • Animals
  • Bacterial Outer Membrane Proteins / immunology*
  • Bacterial Shedding
  • Body Weight
  • Carrier State / diagnosis
  • Carrier State / veterinary
  • Cattle
  • Cattle Diseases / epidemiology
  • Cattle Diseases / immunology
  • Cattle Diseases / prevention & control*
  • Diet
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / immunology
  • Escherichia coli Infections / prevention & control
  • Escherichia coli Infections / veterinary*
  • Escherichia coli O157 / genetics
  • Escherichia coli O157 / growth & development*
  • Escherichia coli O157 / immunology
  • Escherichia coli O157 / isolation & purification
  • Escherichia coli Vaccines* / adverse effects
  • Feces / microbiology
  • Female
  • Intestinal Mucosa / microbiology
  • Male
  • Mass Vaccination / veterinary
  • Porins / immunology*
  • Prevalence
  • Receptors, Cell Surface / immunology*
  • Rectum / microbiology
  • Risk
  • Skin / microbiology
  • Statistics as Topic
  • Time Factors
  • Treatment Outcome

Substances

  • Bacterial Outer Membrane Proteins
  • Escherichia coli Vaccines
  • Porins
  • Receptors, Cell Surface
  • siderophore receptors